Supernus, Inc.

Status: Publicly traded

Last reviewed: November 2026

Direct answer

Supernus, Inc. is publicly traded on NASDAQ under the ticker SUPN.

Supernus, Inc. is a diversified biopharmaceutical company focused on developing and commercializing treatments for central nervous system (CNS) diseases. Its portfolio of 11 marketed products spans opioid use disorder, psychiatry, and neurology, and includes SUBLOCADE, a long-acting injectable buprenorphine for opioid use disorder, along with sublingual OUD treatments; Qelbree, a non-stimulant treatment for...

Can you invest in Supernus, Inc.?

Yes. Supernus, Inc. is publicly traded on NASDAQ under the ticker SUPN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Supernus, Inc.

Detailed equity research is provided by MarketSnap.